Originally published as JHC exPRESS on May 27, 2008. doi:10.1369/jhc.2008.950790
Volume 56 (9): 803-810, 2008 Copyright ©The Histochemical Society, Inc. Immunohistochemical Method Identifies Lymphovascular Invasion in a Majority of Oral Squamous Cell Carcinomas and Discriminates Between Blood and Lymphatic Vessel Invasion
Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania (RKO,RJM); Department of Pathology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania (MF); and Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania (RM) Correspondence to: Rebekah K. O'Donnell, Department of Pathology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215. E-mail: rebekah.k.odonnell{at}gmail.com
Tumor invasion into blood and/or lymphatic channels is an important component of cancer staging and prognosis. Standard pathological methods do not provide sufficient contrast to discriminate between invasion into each type of vessel and are complicated by tissue retraction artifacts. We evaluated the ability of a triple-stain immunohistochemical method, combining cytokeratin, CD34, and podoplanin stains in a single section, to distinguish blood from lymphatic vascular invasion in oral squamous cell carcinoma and confirmed its results using multispectral analysis. The triple-stain method was significantly more sensitive in detecting invasive events than the standard hematoxylin and eosin staining method and easily discriminated between blood and lymphatic vessel invasion. Invasive events were present in blood and/or lymphatic vessels in the majority of patients with and without presentation of lymph node metastasis, indicating that vessel invasion in this cancer model is common and is not a rate-limiting step for lymph node metastasis. (J Histochem Cytochem 56:803–810, 2008)
Key Words: vessel invasion metastasis oral squamous cell carcinoma immunohistochemistry
THE ABILITY of a primary tumor to invade blood or lymphatic vessels is used in staging and prognosis of many human cancers (Greene et al. 2002
Metastasis is the leading cause of death among cancer patients, but the process by which cancer cells establish colonies in new organs is not well understood (Ries et al. 2005 Immunohistochemical (IHC) stains are superior to H and E stains for providing contrast, but are limited by the difficulty of staining a single slide with multiple specific antibodies and the lack of sufficient visual contrast to evaluate overlapping stains. Multispectral imaging provides a means to definitively analyze a single slide for multiple colors. We developed a new triple-staining method that simultaneously labels tumor antigen and blood and lymphatic vessel markers, and tested it on a group of primary oral squamous cell carcinomas (OSCCs). OSCCs are useful for the study of human lymphatic metastasis because of their high frequency of lymphatic metastasis and correlation between metastasis and decreased prognosis. We then evaluated the effectiveness of the triple-stain method in identifying invasion into lymphatic (podoplanin+, CD34+/–) and blood (podoplanin–, CD34+) vessels using a multispectral camera and analysis system.
Study Population Paraffin-embedded slides from 48 patients with newly diagnosed squamous cell carcinoma of the oral cavity were selected from the archives of the Hospital of the University of Pennsylvania upon the basis of pathological lymph node status, absence of distant metastasis, and availability of material. Clinical factors and survival data were obtained from chart review and the Social Security Death Index and subsequently deidentified at the Hospital of the University of Pennsylvania under Institutional Review Board approval. Tumors were pathologically staged according to American Joint Committee on Cancer guidelines. All patient resections were performed at the Hospital of the University of Pennsylvania from 1998 to 2003. Thirty (62.5%) patients were alive at the time of statistical analysis; for these patients, the median follow-up for survival was 4.6 years, with a range of 1.8–7.1 years.
Triple-stain Immunohistochemistry
Multispectral Visualization and Analysis
Statistical Analysis
Triple-stain Immunohistochemistry Three chromagens (DAB, Vector SG, and Vector VIP) were chosen on the basis of limited spectral interference with each other and with the hematoxylin counterstain. At high intensity levels, chromagens may scatter light rather than acting as pure absorbers. To limit light scattering, each chromagen was titrated for intensity vs development time, and a development time was chosen that fell within the linear portion of the intensity curve. Each antibody was tested for efficacy on control skin and tonsil tissue. Pan-cytokeratin antibodies stained epithelial cells, CD34 antibodies stained arteries and small vessels, and podoplanin antibodies stained basal epithelium, small vessels, and a thin reticular network within germinal centers. Tests with tumor tissue showed that pan-cytokeratin consistently stained tumor cytoplasm and that podoplanin often stained tumor cytoplasm, particularly at the basal layer of tumor nests.
Triple stains against cytokeratin, CD34, and podoplanin (Figure 1
) were performed on slides from a series of 48 patients with oral squamous cell carcinoma with a wide range of pathological T and N stages (Table 1
). To compare the results of the triple-stain protocol, which was performed on a single slide per patient, with the standard pathological H and E method, we also examined a single slide from the same block stained by H and E. Invasive events were identified by a combination of cytokeratin staining and malignant cytology. The triple-stain method identified angio/lymphatic vessel invasion (Figure 2
) in 33 patients, compared with 9 for the H and E method (Table 2
). The triple-stain method also identified almost 10 times as many occurrences of vascular invasion (102 invasive events) as the H and E method (13 invasive events), with the most profound increase in the identification of intratumoral invasive events. The invasive events involved both blood and lymphatic vessels and were both intratumoral and peritumoral. Although many instances of blood vessel invasion were identified (23 invasive events), the majority of invasive events were in lymphatic vessels (79 invasive events), and the majority of those events involved a single malignant cell (Table 3
). Multispectral analysis confirmed 88/102 invasive events (86%) and changed the identity of the vessel from CD34+podoplanin– blood to CD34+podoplanin+ lymphatic vessel in five instances (4.9%). Multispectral analysis was shown to be highly concordant with the triple-stain method alone (
Clinical Evaluation Because vascular invasion is an early step in metastasis, we examined the abilities of the different methods to classify patients as N0 or N+ (Table 4 ). In N+ patients, the H and E method identified very few cases with angio/lymphatic invasion, and as a result, had very low sensitivity (25.9% and 22.2% for the standard pathological method using multiple blocks and the single-block H and E, respectively). However, because these methods identified few cases with angio/lymphatic invasion overall, specificity was high (100% and 85.7% for pathological method and single-block H and E, respectively). In N+ patients, the triple-stain method identified invasion in many more cases, and as a result had a much higher sensitivity (81.5%) than the H and E method. But this method also identified invasion in over half of the N0 patients, resulting in a low specificity (47.6%). Even with the misclassification of some N0 patients, the triple-stain method still resulted in the correct classification of the highest number of patients, giving it the highest overall accuracy of the three methods (66.7%).
Using the triple-stain method, the percentage of patients with invasive events was higher in the N+ group than in the N0 group (81.5% vs 52.4%). There was a significant difference between the N+ and N0 groups in the average number of total colonies per patient (2.8 vs 1.2, p=0.04) using the triple-stain method, but not using the H and E method. It is possible that patients with invasive events have a less favorable form of disease. Although the numbers of patients in this study were not sufficient to confirm this hypothesis, we did find that the 11 N0 patients presenting with invasive events showed a poorer prognosis (5-year survival rate + SE; 11.1% + 10.5%) than the 10 N0 patients with no identified invasive events (5-year survival rate + SE; 37.5% + 17.1%, p=0.07), and all 5 patients that presented with a local recurrence also presented with invasive events.
Vessel Quantitation
Tumor infiltration into vessels is an important prognostic factor for many cancers (Greene et al. 2002
Many multicolor staining systems use immunofluorescent reagents (Uchihara et al. 1995
Our work confirms that of Kurtz et al. (2005)
Our work also confirms the results of Van den Eynden et al. (2006)
The high numbers of invasive events and the display of vessel invasion by the majority of N0 patients indicates that vessel invasion is a common instead of a rare occurrence and is not a rate-limiting step in metastasis, consistent with the high numbers of tumor cells frequently present in the bloodstream and lymphatics that are not correlated with the presence of metastasis (Hewitt and Blake 1975 The clinical significance of vessel invasion is not clear at this time, owing to the large number of N0 patients that displayed vessel invasion, although vessel invasion may possibly indicate a more dangerous phenotype, identifying patients who could benefit from further treatment. The number of patients, when subdivided, was insufficient to draw conclusions in this study. Future studies will determine the clinical significance of vessel invasion, which may potentially differ across types of disease.
Despite the growing literature correlating lymphangiogenesis, usually assessed by the quantitation of vessels in hot spots, with metastasis, the presence of vessel invasion in these patients was not linked with the number of lymphatic vessels, nor with any distinction between podoplanin+CD34– and podoplanin+CD34+ vessels (Beasley et al. 2002 By easily identifying a much larger group of invasive events, this method should allow the field to study the process of vessel invasion in more detail. A better understanding of the phenotype of the vessels being invaded may resolve the question of whether the correlation between lymphangiogenesis and metastasis is because a newly formed vessel is easier to invade, or because a tumor that is able to invade also spurs lymphangiogenesis. Improved information about a primary tumor's true capabilities must be beneficial to patients in the long term.
This work was supported by University of Pennsylvania Cancer Center Support Grant CA-016520 (to RM). The authors thank Wendy Snyder, Clinical Research Coordinator of the Department of Otorhinolaryngology at the Hospital of the University of Pennsylvania, for her assistance in collecting patient data, and Danielle Murphy of the University of Pennsylvania for helpful advice about multicolor staining.
Received for publication January 20, 2008; accepted May 5, 2008
Alitalo K, Tammela T, Petrova TV (2005) Lymphangiogenesis in development and human disease. Nature 438:946–953[CrossRef][Medline] Beasley NJ, Prevo R, Banerji S, Leek RD, Moore J, van Trappen P, Cox G, et al. (2002) Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62:1315–1320 Cao Y (2005) Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 5:735–743[CrossRef][Medline] Fidler IJ, Gersten DM, Hart IR (1978) The biology of cancer invasion and metastasis. Adv Cancer Res 28:149–250[Medline] Fiedler U, Christian S, Koidl S, Bates DO, Christofori G, Augustin H (2006) The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors. Am J Pathol 168:1045–1053 Fleiss J (1981) Statistical Methods for Rates and Proportions. 2nd ed. New York, Wiley Franchi A, Gallo O, Massi D, Baroni G, Santucci M (2004) Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer 101:973–978[CrossRef][Medline] Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, eds (2002) AJCC Cancer Staging Manual. New York, Springer-Verlag Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70[CrossRef][Medline] Hewitt H, Blake E (1975) Quantitative studies of translymphnodal passage of tumor cells naturally disseminated from a non-immunogenic murine squamous carcinoma. Br J Cancer 31:25–35[Medline] Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481[CrossRef] Kurtz KA, Hoffman HT, Zimmerman B, Robinson RA (2005) Perineural and vascular invasion in oral cavity squamous carcinoma. Arch Pathol Lab Med 129:354–359[Medline] Kyzas P, Geleff S, Batistatou A, Agnantis NJ, Stefanou D (2005) Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 206:170–177[CrossRef][Medline] Landis J, Koch C (1977) The measurement of interrater agreement for categorical data. Biometrics 33:159–174[CrossRef][Medline] Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163–170[Medline] Maula SM, Luukkaa M, Grenman R, Jackson D, Jalkanen S, Ristamaki R (2003) Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 63:1920–1926 Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 1:99–101[CrossRef] Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW, Uhr JW (1998) Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 95:4589–4594 Ries L, Harkins D, Krapcho M, Mariotto A, Miller B, Feuer E, Clegg L, et al., eds (2005) SEER Cancer Statistics Review, 1975–2003. Bethesda, MD, National Cancer Institute. http://seer.cancer.gov/csr/1975_2003/ (based on November 2005 SEER data submission) Sleeman JP, Krishnan J, Kirkin V, Baumann P (2001) Markers for the lymphatic endothelium: in search of the Holy Grail? Microsc Res Tech 55:61–69[CrossRef][Medline] Tarin D, Price JE, Kettlewell MG, Souter RG, Vass AC, Crossley B (1984) Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res 44:3584–3592 Uchihara T, Kondo H, Akiyama H, Ikeda K (1995) Single-laser three-color immunolabeling of a histological section by laser scanning microscopy: application to senile plaque-related structures in post-mortem human brain tissue. J Histochem Cytochem 43:103–106[Abstract] Van den Eynden G, Van der Auwera I, Van Laere S, Colpaert C, van Dam P, Dirix L, Vermeulen P, et al. (2006) Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study. Br J Cancer 94:1643–1649[Medline] Van Vlierberghe RL, Sandel MH, Prins FA, van Iersel LB, van de Velde CJ, Tollenaar RA, Kuppen PJ (2005) Four-color staining combining fluorescence and brightfield microscopy for simultaneous immune cell phenotyping and localization in tumor tissue sections. Microsc Res Tech 67:15–21[CrossRef][Medline] Wahlby C, Erlandsson F, Bengtsson E, Zetterberg A (2002) Sequential immunofluorescence staining and image analysis for detection of large numbers of antigens in individual cell nuclei. Cytometry 47:32–41[CrossRef][Medline] Xuan M, Fang Y-R, Wato M, Hata S, Tanaka A (2005) Immunohistochemical co-localization of lymphatics and blood vessels in oral squamous cell carcinomas. J Oral Pathol Med 34:334–339[CrossRef][Medline]
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||